Experience in the application of ultrasound indices for assessing the activity of inflammatory bowel diseases
Open Access
- 28 August 2025
- journal article
- abstracts
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (8) , 680-688
Abstract
Aim. To evaluate the diagnostic value of ultrasound (US) parameters and indices for assessing the active inflammatory bowel diseases (IBD). Materials and methods. The study included 115 patients with IBD, 41 (36%) patients were with ulcerative colitis (UC) and 74 (64%) – with Crohn's disease (CD). Transabdominal US examination of the intestine was performed on Sonoscape S2N, with a bowel wall thickness (BWT) of 3 mm considered the norm. To assess activity in UC, the Milan Ultrasound Criteria (MUC) score was used, and in CD – International Bowel Ultrasound Segmental Activity Score (IBUS-SAS). Results. In active UC BWT (5.91 [4.87; 6.95] mm) was greater than in remission (2.9 [2.6; 3.1] mm; p = 0.003). For active UC diagnosis BWT greater than 3 mm had sensitivity (Se) of 90.5% and specificity (Sp) of 70.6%. The MUC in exacerbation (9 [7.88; 11.8]) was higher than in remission (4.2 [3.64; 4.9]; p 0.001). In 31 (89%) patients in exacerbation, the MUC was higher than 6.2 (Se 88.9%, Sp 87.5%), and in 34 (97%) at a threshold of 5.18 (Se 96.3%, Sp 87.5%). In active CD, BWT (4.9 [3.8; 6.6] mm) was greater than in remission (3.18 [2.6; 3.5]; p = 0.0001), with Se 87.0%, Sp 71.4%. The IBUS-SAS in active CD (46.8 [27; 71.5]) was higher than the remission (12.6 [11.2; 30.2]; p = 0.001). At a threshold of 37.5, the IBUS-SAS had Se 92.6%, Sp 61.5%, and at 45.2, Se 92.6%, Sp 87.2%. Conclusion. US imaging is a useful and effective tool for assessing IBD activity; a threshold value of the MUC score of 5.18 and IBUS-SAS of 45.2 suggests better diagnostic value for differentiating between exacerbation and remission.Keywords
This publication has 17 references indexed in Scilit:
- Clinical Application of Intestinal Ultrasound in Inflammatory Bowel DiseaseCurrent Gastroenterology Reports, 2024
- P400 Experience with the use of intestinal ultrasound and application of the Milan Ultrasound Criteria in Colombian patients with ulcerative colitisJournal of Crohn's and Colitis, 2024
- P199 External validation of Intestinal Ultrasound score: IBUS-SAS with clinical (CDAI), biomarkers and endoscopic scoring system (SES-CD)Journal of Crohn's and Colitis, 2024
- Ultrasonographic scores for ileal Crohn’s disease assessment: Better, worse or the same as contrast-enhanced ultrasound?BMC Gastroenterology, 2022
- Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus StatementJournal of Crohn's and Colitis, 2021
- STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBDGastroenterology, 2021
- Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validationUnited European Gastroenterology Journal, 2021
- Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn’s DiseaseJournal of Crohn's and Colitis, 2020
- ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspectsJournal of Crohn's and Colitis, 2018
- Ultrasound as a diagnostic tool in detecting active Crohn’s disease: a meta-analysis of prospective studiesEuropean Radiology, 2013